Target intelligence / Profile preview

Gut bacteriophage

Molecular classification
Virus, Other
01

Overview

Gut bacteriophages are viruses that specifically infect bacteria residing within the gastrointestinal tract. They represent the most abundant viral entities in the human gut ecosystem, where they play crucial roles in shaping microbial community structure by lysing specific bacterial populations, facilitating horizontal gene transfer, and influencing overall microbial diversity. The "gut bacteriophage profile" refers not to a single molecular target but rather to the collective population structure—also called the "phageome"—of these viruses within an individual's digestive tract. These profiles are highly individualized and can be temporally stable yet responsive to environmental factors such as diet or antibiotic use. Bacteriophages have been explored as therapeutic agents ("phage therapy") for treating multidrug-resistant bacterial infections due to their specificity for certain pathogens while sparing commensal flora. Their ability to disrupt biofilms further enhances their therapeutic potential compared to conventional antibiotics. However, their role is double-edged; imbalances or shifts in phage populations have been implicated in various intestinal disorders through mechanisms involving altered metabolite release from lysed bacteria and direct activation of host immunity. Despite growing interest, much about gut bacteriophage biology remains poorly understood—including their full diversity ("viral dark matter"), precise functions within health and disease contexts, optimal methods for profiling them accurately across studies, and long-term safety implications when used therapeutically.[1][3][4][5] **Note:** "Gut bacteriophage profiles" is not a canonical molecular target but rather a descriptive term referring collectively to all phages present in the gut at any given time; it does not denote a single receptor/protein/target suitable for drug development pipelines. Therefore: **is_target:** false **is_incorrect:** true — This entry describes a population-level feature rather than an individual molecule/receptor/enzyme typically considered as a drug target.[1][3][5]

Other names
BacteriophagePhageGut phageHuman gut virome (context-dependent)
02

Mechanism of action

Lysis of specific bacterial hosts via infection and replication within bacteria[1][3][4]; Disruption of biofilms formed by pathogenic bacteria[4]; Modulation of immune responses through direct or indirect interactions with the host immune system[4]

03

Biological functions

Modulation of gut microbiome compositionHorizontal gene transfer among bacteriaRegulation of bacterial diversity and abundanceInteraction with host immune system
04

Disease associations

Infection (as therapeutic agents against bacterial infections)Inflammation (implicated in intestinal inflammatory disorders)Other (potential roles in gastrointestinal diseases and modulation of disease states)
05

Safety considerations

Immune activation due to administration route or residual bacterial components in preparations[2]Limited understanding of long-term effects on microbiota balance and human health[5]
06

Biomarkers

Changes in gut phageome composition as potential biomarkers for dysbiosis or disease states[5]

Beyond the preview

Go deeper on Gut bacteriophage.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut bacteriophage.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call